Description

Flutixon (Fluticasonum) Hard Capsules 250 mcg. №60 Powder for Inhalation

Composition

Each hard capsule contains 250 mcg of Fluticasonum.

Mechanism of Action

Flutixon, a corticosteroid, acts by reducing inflammation in the airways, thereby improving lung function and alleviating asthma symptoms such as wheezing, shortness of breath, and coughing.

Pharmacological Properties

Flutixon is a corticosteroid that exerts anti-inflammatory effects in the respiratory system, aiding in the prevention of asthma exacerbations and maintaining respiratory health.

Indications for Use

Flutixon is indicated for the maintenance treatment of asthma as prophylactic therapy to control symptoms and prevent asthma attacks.

Contraindications

Avoid using Flutixon if you have a known allergy to Fluticasonum or any other components of the product to prevent adverse reactions.

Side Effects

Possible side effects of Flutixon may include throat irritation, cough, hoarseness, and oral thrush. Consult your healthcare provider if you experience any concerning side effects.

Usage Instructions

The typical dosage involves inhaling one capsule orally daily as directed by your healthcare professional for optimal asthma management.

Advantages Over Analogues

Compared to other inhaled corticosteroids, Flutixon has demonstrated comparable effectiveness in controlling asthma symptoms and reducing the frequency of asthma attacks, making it a reliable option for long-term asthma management.

Suitable Patient Groups

Flutixon is suitable for both adult and pediatric patients requiring prophylactic asthma treatment. Dosage adjustments may be necessary for elderly individuals based on individual health needs.

Storage and Shelf Life

Store Flutixon in a cool, dry place away from direct sunlight within the specified temperature range. Check the product packaging for the expiration date and adhere to proper storage conditions for optimal efficacy.

Packaging Description

Flutixon is available in packages containing 60 hard capsules of 250 mcg each, designed for convenient inhalation administration.

Clinical Evidence and Effectiveness

Studies have shown that Flutixon is effective in reducing asthma symptoms and improving lung function. Notably, a study published in the Journal of Allergy and Clinical Immunology revealed a significant reduction in asthma exacerbations with Flutixon compared to a placebo.